Pacific Biosciences Of California PACB
NASDAQ PACB
$2.54 +0.03 (+1.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pacific Biosciences Of California (PACB) Price to Earnings (2020)

Updated

Pacific Biosciences Of California's Price to Earnings came in at 169.65 for Q4 2020.

Analysis

Pacific Biosciences Of California (PACB) Price to Earnings (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Pacific Biosciences Of California 789.46 Mn -301.54 Mn 12.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 169.65
API Access

Pacific Biosciences Of California Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PACB&period=max&api_key=YOUR_API_KEY